NCT00412321 2014-07-01A Safety and Efficacy Study of CNTO 328 in Patients With B-Cell Non-Hodgkin's Lymphoma, Multiple Myeloma, or Castleman's DiseaseCentocor, Inc.Phase 1 Completed67 enrolled
NCT00891280 2011-06-15Dose-escalation Study of Oral CX-4945Cylene PharmaceuticalsPhase 1 Unknown55 enrolled